Understanding Potential Advantages Of Neoadjuvant Immunotherapy For Melanoma
Exploring Potential Advantages Of Neoadjuvant Immunotherapy For Melanoma reveals several interesting facts. Sapna Patel, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the
Key Takeaways about Potential Advantages Of Neoadjuvant Immunotherapy For Melanoma
- Dr Sapna Patel speaks to ecancer about the SWOG S1801 trial which studied the use of neoadjvuant versus adjuvant ...
- Atkins says because treatments currently used in patients with visible metastatic
- Dr. Katy Tsai, MD, Associate Professor of Clinical Medicine and Medical Director of the
- Andtbacka says the standard of care is interferon, with biochemotherapy also being offered or ipilimumab. Despite this, Andtbacka ...
- Experts in the treatment of patients with
Detailed Analysis of Potential Advantages Of Neoadjuvant Immunotherapy For Melanoma
Sapna Patel, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, talks on SWOG S1801 (NCT03698019), ... Omid Hamid, MD, The Angeles Clinic and Research Institute, Los Angeles, CA, discusses the role of Jeffrey S. Weber, MD, PhD; Robert Andtbacka, MD, CM; Jason J. Luke, MD, FACP; and Hussein Tawbi, MD, PhD, remark on ...
This video is from the Animated Patient's Guide to
Stay tuned for more updates related to Potential Advantages Of Neoadjuvant Immunotherapy For Melanoma.
